Cystatin C and Uncontrolled Hypertension

Completed

• Conditions: Uncontrolled Hypertension

• Registration Number: NCT02334033
• Lead Sponsor: Ankara University

Brief Summary

Hypertension is an underdiagnosed and undertreated disease in real-life. Blood pressure and kidney functions are known to be closely related. Increased serum level of Cystatin C, a sensitive biomarker for renal function, seems to predict adverse cardiovascular events. The investigators aimed to evaluate the predictive value of serum Cystatin C for control of hypertension in a community-based study.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-01
• Status Verified: 2015-01
• Primary Completion: 2015-01
• Study Completion: 2015-01
• Study First Submitted: 2015-01-02
• Study First Submitted QC: 2015-01-06
• Study First Posted: 2015-01-08
• Last Update Submitted: 2015-01-24
• Last Update Posted: 2015-01-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 903

Inclusion Criteria

• Individuals who accept to participate to the survey
• > 18 years

Exclusion Criteria

• Individuals who are not able to complete the questionnaire
• Individuals who didn't give informed consent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The prevalence of uncontrolled hypertension	At subject enrollment	The outcome measures will be obtained at the time of enrollment

Secondary Outcome Measures

Name	Time	Method
The value of cystatin C to determine uncontrolled hypertension	At subject enrollment	The outcome measures will be obtained at the time of enrollment

Trial Locations

Locations (1)

Ankara University School Of Medicine, Department of Cardiology; 🇹🇷 Ankara, Turkey